论文部分内容阅读
加拿大多伦多 1997.12.2Novartls Pharmatical 加拿大跨国公司今日宣布该公司抗高血压新药 PrDiovam(Valsartan)血管紧张素Ⅱ拮抗剂已经获得了加拿大市场认证。该药为最新的抗高血压药物。通过与使用同剂量安慰剂的对照组对比,显示该药
Toronto, Canada 1997.12.2 Novartis Pharmatical Canadian multinationals announced today that their anti-hypertensive drug PrDiovam (Valsartan) has been accredited by the Canadian market for its angiotensin II antagonist. The drug is the latest antihypertensive drug. The drug was shown to be contrasted with a control group using the same dose of placebo